NIH-funded research R21 grant

Blocking skin wound infections by disrupting bacterial communication

Official title: Strategies to Block Skin Wound Infection by Intercepting Bacterial Cell-to-Cell Signaling

Funded at University of Wisconsin-Madison · NIH-10769891 · Data updated 2026-11-12

This study is looking at new ways to stop bacterial infections in skin wounds without using traditional antibiotics, which is great news for anyone worried about antibiotic resistance.

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionUniversity of Wisconsin-Madison
NIH-funded
Lab location1 site (Madison, United States)
Project startFebruary 1, 2023
Project endJanuary 31, 2026
Funding year2024
Award (this year)$184,385
NIH project number5R21AI171762-02
Project IDNIH-10769891 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals with skin wounds at risk of bacterial infection, particularly those with antibiotic-resistant infections.

Less likely to help

Patients with skin wounds that are not infected or those who do not have a history of bacterial infections may not benefit from this research.

What this research studies

This research focuses on developing new materials that can prevent bacterial infections in skin wounds by using chemical inhibitors to disrupt bacterial cell-to-cell signaling. It aims to tackle the growing problem of antibiotic resistance by targeting the mechanisms that bacteria use to coordinate their attacks on the host. By interfering with a process known as quorum sensing, which bacteria use to regulate their virulence, this approach could lead to innovative treatments that do not rely on traditional antibiotics. The project addresses a significant health issue affecting millions of patients and seeks to provide a novel solution to improve patient outcomes.

Why it matters

Potential benefit: If successful, this research could lead to new treatments that effectively prevent skin wound infections, reducing suffering and healthcare costs for patients.

How similar studies have gone: Other research has shown promise in targeting bacterial communication pathways, indicating that this approach could be a viable and innovative strategy in infection control.

Where this research is happening

  • University of Wisconsin-Madison
    Madison, United States
    Active

Researchers

  • Principal investigator: Blackwell, Helen E. — University of Wisconsin-Madison
  • Study coordinator: Blackwell, Helen E.

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.